A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD

Clinical trial NCT07076290 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07076290
Sponsor: Rise Therapeutics LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)COPD Exacerbation COPD Exacerbation Acute

Start date: 2026-09-01
Primary completion: 2028-04-30
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.